Medigene AG: Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharm…
- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharm…
Medigene AG (MDG1, Frankfurt, Prime Standard, TecDAX) announces that a scientific article on a method to identify T cell…
Die Medigene AG (MDG1, Frankfurt, Prime Standard, TecDAX) gibt bekannt, dass ein wissenschaftlicher Artikel über eine Me…
The Executive Management Board of Medigene AG (FSE: MDG1, Prime Standard, TecDAX) with the approval of the Company's Sup…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX), will demonstrate the use of its automated high-throughput screening (HT…
- Automated in vitro testing could reveal better neoantigens that activate more effective killer T cell responses - Two…
. - First poster reports of a semi-automated method for the isolation and initial characterization of neoantigen-specif…
. - Das erste Poster zeigt die halbautomatisierte Methode zur Isolierung und anfänglichen Charakterisierung von neoanti…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced the appointment of eight leading experts to its new immu…
Article in "Cancer Research" published in collaboration with scientists from nine academic research groups in Berlin, Mu…